Article
Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases.
Journal of neuro-oncology - 1 Oct 2023
Bai Kaixuan, Chen Xin, Qi Xuejiao, Zhang Yu, Zou Yueli, Li Jian, Yu Lili, Li Yuanyuan, Jiang Jiajia, Yang Yi, Liu Yajing, Feng Shuanghao, Bu Hui
Abstract excerpt
PURPOSE: The prognosis of patients with leptomeningeal metastasis (LM) remains poor. Circulating tumour DNA (ctDNA) has been proven to be abundantly present in cerebrospinal fluid (CSF); hence, its clinical implication as a biomarker needs to be further verified. METHODS: We conducted a retrospective study of 35 lung adenocarcinoma (LUAD) patients with LM, and matched CSF and plasma samples were collected from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
